This page sets out IVF Pay's Target Market Determinations (TMDs) for its loan products, as required under the National Consumer Credit Protection Act 2009. Select the product below to view the relevant determination.
| Issuer | IVF Pay Pty Ltd (ABN: 86 693 531 958) (Australian Credit Licence 576437) |
| Effective Date | 1 July 2026 |
| Product | IVF Pay's Medium Amount Loan — an unsecured personal loan of $2,001 to $5,000, for a term of 6 months to 2 years, to cover the cost of fertility treatments in Australia. |
The purpose of this Target Market Determination is to provide consumers and distributors with information about the class of consumers for which the Product is designed.
IVF Pay is committed to creating and maintaining a consumer-centric approach to the design and distribution of its Products.
This TMD does not contain all the information a consumer may require before making a decision to acquire the Product. It does not provide financial advice and does not take into account any particular consumer's objectives, financial situation or needs. Consumers should refer to the Credit Guide, Loan Contract and other product documents available at ivfpay.au.
| Target consumer | Key product attribute |
|---|---|
| Wishes to undergo fertility treatment in Australia, including IVF, IUI, FET and other assisted reproductive procedures | — |
| Wishes to understand their indicative borrowing capacity to support treatment planning and financial decision-making | Pre-approval process: IVF Pay conducts a pre-approval process so consumers can understand their borrowing capacity upfront and plan their treatments accordingly. |
| Seeking a loan of $2,001–$5,000 to cover specific aspects of fertility treatment or gap finance | Amount: $2,001–$5,000 · Term: 6 months – 2 years |
| Requires a fixed interest rate | Interest rate: Fixed rate for the life of the loan. |
| Requires flexibility to make extra repayments | No early repayment fees: Extra repayments or full payout at any time, no fees or charges. |
IVF Pay has assessed the Product and formed the view that the Product, including its key attributes, is likely to be consistent with the likely objectives, financial situation and needs of consumers in the Target Market. The Product enables consumers to access finance for fertility treatment in a time- and needs-sensitive manner and is consistent with the needs of consumers seeking flexibility in relation to repayment arrangements.
Distribution channels
The Product is designed to be distributed by the Issuer only via its Website. As at the date of this TMD, the Issuer is the sole distributor of the Product.
Sales staff requirements
Distribution conditions
| Initial Review | Within 12 months of the effective date of this TMD. |
| Periodic Reviews | At least every 12 months from the last review. |
| Review Triggers |
|
All complaints are reported on a monthly basis, including written details of each complaint.
Any significant dealing is reported to IVF Pay within 10 business days of becoming aware.
All consumer feedback on product performance is reported on a quarterly basis.
| Issuer | IVF Pay Pty Ltd (ABN: 86 693 531 958) (Australian Credit Licence 576437) |
| Effective Date | 1 July 2026 |
| Product | IVF Pay's Large Amount Loan — an unsecured personal loan of $5,001 to $15,000, for a term of 1 to 5 years, to cover the cost of fertility treatments in Australia. |
The purpose of this Target Market Determination is to provide consumers and distributors with information about the class of consumers for which the Product is designed.
IVF Pay is committed to creating and maintaining a consumer-centric approach to the design and distribution of its Products.
This TMD does not contain all the information a consumer may require before making a decision to acquire the Product. It does not provide financial advice and does not take into account any particular consumer's objectives, financial situation or needs. Consumers should refer to the Credit Guide, Loan Contract and other product documents available at ivfpay.au.
| Target consumer | Key product attribute |
|---|---|
| Wishes to undergo fertility treatment in Australia, including IVF, IUI, FET and other assisted reproductive procedures | — |
| Wishes to understand their indicative borrowing capacity to support treatment planning and financial decision-making | Pre-approval process: IVF Pay conducts a pre-approval process so consumers can understand their borrowing capacity upfront and plan their treatments accordingly. |
| Seeking a loan of $5,001–$15,000 to cover the costs of fertility treatments | Amount: $5,001–$15,000 · Term: 1–5 years |
| Requires a fixed interest rate | Interest rate: Fixed rate for the life of the loan. |
| Requires flexibility to make extra repayments | No early repayment fees: Extra repayments or full payout at any time, no fees or charges. |
| Experiences temporary changes to income or employment during treatment and recovery and requires flexibility to make lower repayments | Interest-only option: Consumers can opt in to interest-only repayments for up to 12 months. |
IVF Pay has assessed the Product and formed the view that the Product, including its key attributes, is likely to be consistent with the likely objectives, financial situation and needs of consumers in the Target Market. The Product enables consumers to access finance for fertility treatment in a time- and needs-sensitive manner and is consistent with the needs of consumers seeking flexibility in relation to repayment arrangements, including via the interest-only option.
Distribution channels
The Product is designed to be distributed by the Issuer only via its Website. As at the date of this TMD, the Issuer is the sole distributor of the Product.
Sales staff requirements
Distribution conditions
| Initial Review | Within 12 months of the effective date of this TMD. |
| Periodic Reviews | At least every 12 months from the last review. |
| Review Triggers |
|
All complaints are reported on a monthly basis, including written details of each complaint.
Any significant dealing is reported to IVF Pay within 10 business days of becoming aware.
All consumer feedback on product performance is reported on a quarterly basis.
IVF Pay Pty Ltd · Australian Credit Licence 576437 · Gold Coast, Queensland
Effective 1 July 2026 · This document is reviewed in accordance with IVF Pay's TMD review schedule.